These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [10 years of L-DOPA therapy of Parkinson's syndrome]. Birkmayer W. Wien Klin Wochenschr; 1971 Apr 02; 83(13):221-7. PubMed ID: 4254333 [No Abstract] [Full Text] [Related]
6. [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease]. Schneider E, Fischer PA, Jacobi P, Maxion H. Arch Psychiatr Nervenkr (1970); 1973 Mar 19; 217(1):95-112. PubMed ID: 4695662 [No Abstract] [Full Text] [Related]
8. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E. Practitioner; 1972 Apr 19; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
9. Ro 4-4602 and levodopa in the treatment of Parkinsonism. Miller EM, Wiener L. Neurology; 1974 May 19; 24(5):482-6. PubMed ID: 4857107 [No Abstract] [Full Text] [Related]
11. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Fahn S. Neurology; 1974 May 19; 24(5):431-41. PubMed ID: 4857104 [No Abstract] [Full Text] [Related]
12. [L-tryptophan therapy of DOPA psychoses]. Birkmayer W, Neumayer E. Nervenarzt; 1972 Feb 19; 43(2):76-8. PubMed ID: 4501978 [No Abstract] [Full Text] [Related]